In Vivo Characterization of the Murine Intranasal Model for Assessing the Immunogenicity of AttenuatedSalmonella entericaSerovar Typhi Strains as Live Mucosal Vaccines and as Live Vectors
Open Access
- 1 January 2000
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (1) , 205-213
- https://doi.org/10.1128/iai.68.1.205-213.2000
Abstract
AttenuatedSalmonella entericaserovar Typhi live vector vaccine strains are highly immunogenic in mice following intranasal but not orogastric inoculation. To elucidate the relationship between organs within which vaccine organisms are found and the induction of specific serum immunoglobulin G (IgG) antibodies, we examined the in vivo distribution of serovar Typhi vaccine strain CVD 908-htrAfollowing intranasal administration. Vaccine organisms were cultured from the nasal lymphoid tissue (NALT), lungs, and Peyer's patches 2 min after intranasal inoculation. Vaccine organisms persisted longer in NALT than in other organs. By decreasing the volume of intranasal inoculum containing 109CFU (from a single 30- or 10-μl dose to four 2.5-μl doses given over the course of 1 h), we were able to significantly reduce the number of vaccine organisms isolated from the lungs (P< 0.05) without reducing the number of vaccine organisms in NALT. Reducing the number of vaccine organisms in the lungs resulted in a significant decrease in the serum tetanus antitoxin response elicited by CVD 908-htrAexpressing tetanus toxin fragment C under the control of the redox-responsivenir15promoter. In contrast, a similar construct expressing tetanus toxin fragment C under control of the constitutivelpppromoter stimulated a strong serum IgG tetanus antitoxin response with both inoculation regimens. The data suggest that following intranasal inoculation, NALT is a sufficient inductive site for elicitation of an immune response against both the live vector and heterologous antigen and, as occurs following oral inoculation of humans, attenuated serovar Typhi vaccine organisms elicit serum IgG responses.Keywords
This publication has 18 references indexed in Scilit:
- Attenuated ΔguaBA Salmonella typhi Vaccine Strain CVD 915 as a Live Vector Utilizing Prokaryotic or Eukaryotic Expression Systems to Deliver Foreign Antigens and Elicit Immune ResponsesClinical Immunology, 1999
- phoP/phoQ-Deleted Salmonella typhi (Ty800) Is a Safe and Immunogenic Single Dose Typhoid Fever Vaccine in VolunteersThe Journal of Infectious Diseases, 1996
- Expression of LacZ from thehtrA, nirBandgroEpromoters in aSalmonellavaccine strain: Influence of growth in mammalian cellsFEMS Microbiology Letters, 1995
- Salmonella typhi Vaccine Strain CVD 908 Expressing the Circumsporozoite Protein of Plasmodium falciparum: Strain Construction and Safety and Immunogenicity in HumansThe Journal of Infectious Diseases, 1994
- Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.Journal of Clinical Investigation, 1992
- Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus VaccineNature Biotechnology, 1992
- Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strainVaccine, 1992
- Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human originMicrobial Pathogenesis, 1990
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981
- THE ROUTE OF ENTERIC INFECTION IN NORMAL MICEThe Journal of Experimental Medicine, 1974